Yi-Dan H, Ying-Xin Z, Shi-Wei Y, Yu-Jie Z
Front Cardiovasc Med. 2021; 8:675608.
PMID: 34395552
PMC: 8355518.
DOI: 10.3389/fcvm.2021.675608.
Pfaffenzeller M, Franciosi M, Cardoso A
Purinergic Signal. 2020; 16(1):123-135.
PMID: 32170538
PMC: 7166227.
DOI: 10.1007/s11302-020-09693-3.
Burnstock G
Purinergic Signal. 2015; 11(4):411-34.
PMID: 26260710
PMC: 4648797.
DOI: 10.1007/s11302-015-9462-7.
Cattaneo M
Purinergic Signal. 2011; 7(3):333-9.
PMID: 21484091
PMC: 3166989.
DOI: 10.1007/s11302-011-9217-z.
Mahaut-Smith M, Jones S, Evans R
Purinergic Signal. 2011; 7(3):341-56.
PMID: 21484087
PMC: 3166991.
DOI: 10.1007/s11302-011-9224-0.
Historical perspective on ADP-induced platelet activation.
Packham M, Rand M
Purinergic Signal. 2011; 7(3):283-92.
PMID: 21484086
PMC: 3166988.
DOI: 10.1007/s11302-011-9227-x.
Platelets in defense against bacterial pathogens.
Yeaman M
Cell Mol Life Sci. 2009; 67(4):525-44.
PMID: 20013024
PMC: 2809947.
DOI: 10.1007/s00018-009-0210-4.
Staphylococcus aureus, Platelets, and the Heart.
Yeaman , Bayer
Curr Infect Dis Rep. 2000; 2(4):281-298.
PMID: 11095867
DOI: 10.1007/s11908-000-0005-0.
ADP can induce aggregation of human platelets via both P2Y(1) and P(2T) receptors.
Jarvis G, Humphries R, Robertson M, Leff P
Br J Pharmacol. 2000; 129(2):275-82.
PMID: 10694233
PMC: 1571831.
DOI: 10.1038/sj.bjp.0703046.
Continuous detection of extracellular ATP on living cells by using atomic force microscopy.
Schneider S, Egan M, Jena B, Guggino W, Oberleithner H, Geibel J
Proc Natl Acad Sci U S A. 1999; 96(21):12180-5.
PMID: 10518596
PMC: 18432.
DOI: 10.1073/pnas.96.21.12180.
P2 receptor subtypes in the cardiovascular system.
Kunapuli S, Daniel J
Biochem J. 1998; 336 ( Pt 3):513-23.
PMID: 9841859
PMC: 1219898.
DOI: 10.1042/bj3360513.
Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation.
Jin J, Kunapuli S
Proc Natl Acad Sci U S A. 1998; 95(14):8070-4.
PMID: 9653141
PMC: 20930.
DOI: 10.1073/pnas.95.14.8070.
Identification of a receptor for ADP on blood platelets by photoaffinity labelling.
Cristalli G, MILLS D
Biochem J. 1993; 291 ( Pt 3):875-81.
PMID: 8387782
PMC: 1132450.
DOI: 10.1042/bj2910875.
FPL 66096: a novel, highly potent and selective antagonist at human platelet P2T-purinoceptors.
Humphries R, Tomlinson W, Ingall A, Cage P, Leff P
Br J Pharmacol. 1994; 113(3):1057-63.
PMID: 7858849
PMC: 1510445.
DOI: 10.1111/j.1476-5381.1994.tb17100.x.
Mobilization of intracellular Ca2+ by adenine nucleotides in human T-leukaemia cells: evidence for ADP-specific and P2y-purinergic receptors.
Biffen M, Alexander D
Biochem J. 1994; 304 ( Pt 3):769-74.
PMID: 7818479
PMC: 1137400.
DOI: 10.1042/bj3040769.
An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb-IIIa complex function.
Nurden P, Savi P, Heilmann E, Bihour C, Herbert J, Maffrand J
J Clin Invest. 1995; 95(4):1612-22.
PMID: 7706468
PMC: 295660.
DOI: 10.1172/JCI117835.
Pharmacological profile of the novel P2T-purinoceptor antagonist, FPL 67085 in vitro and in the anaesthetized rat in vivo.
Humphries R, Tomlinson W, CLEGG J, Ingall A, Kindon N, Leff P
Br J Pharmacol. 1995; 115(6):1110-6.
PMID: 7582510
PMC: 1909008.
DOI: 10.1111/j.1476-5381.1995.tb15925.x.
Effects of RP and SP diastereoisomers of adenosine 5'-O-(1-thiodiphosphate) on human platelets.
Cusack N, Hourani S
Br J Pharmacol. 1981; 73(2):409-12.
PMID: 7236993
PMC: 2071675.
DOI: 10.1111/j.1476-5381.1981.tb10437.x.
Partial agonist behaviour of adenosine 5'-O-(2-thiodiphosphate) on human platelets.
Cusack N, Hourani S
Br J Pharmacol. 1981; 73(2):405-8.
PMID: 7236992
PMC: 2071680.
DOI: 10.1111/j.1476-5381.1981.tb10436.x.
Specific but noncompetitive inhibition by 2-alkylthio analogues of adenosine 5'-monophosphate and adenosine 5'-triphosphate of human platelet aggregation induced by adenosine 5'-diphosphate.
Cusack N, Hourani S
Br J Pharmacol. 1982; 75(2):397-400.
PMID: 7186826
PMC: 2071616.
DOI: 10.1111/j.1476-5381.1982.tb08800.x.